X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Pfizer with SUVEN LIFE - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

PFIZER vs SUVEN LIFE - Comparison Results

PFIZER    Change

Pfizer India is a 71% subsidiary of the world's largest pharmaceuticals company Pfizer Inc. Pfizer derives a larger share of its revenues from the pharmaceuticals division (81%). The company also has presence in the animal health (13%) and clinical d... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    PFIZER SUVEN LIFE PFIZER/
SUVEN LIFE
 
P/E (TTM) x 31.2 19.2 163.1% View Chart
P/BV x 5.0 3.6 139.8% View Chart
Dividend Yield % 0.7 1.1 61.9%  

Financials

 PFIZER   SUVEN LIFE
EQUITY SHARE DATA
    PFIZER
Mar-16
SUVEN LIFE
Mar-16
PFIZER/
SUVEN LIFE
5-Yr Chart
Click to enlarge
High Rs2,724339 804.7%   
Low Rs1,611144 1,115.7%   
Sales per share (Unadj.) Rs440.939.2 1,123.4%  
Earnings per share (Unadj.) Rs48.77.5 652.6%  
Cash flow per share (Unadj.) Rs75.88.8 863.5%  
Dividends per share (Unadj.) Rs15.002.00 750.0%  
Dividend yield (eoy) %0.70.8 83.5%  
Book value per share (Unadj.) Rs462.949.0 944.8%  
Shares outstanding (eoy) m45.75127.28 35.9%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x4.96.2 79.9%   
Avg P/E ratio x44.532.4 137.6%  
P/CF ratio (eoy) x28.627.5 104.0%  
Price / Book Value ratio x4.74.9 95.0%  
Dividend payout %30.826.8 114.9%   
Avg Mkt Cap Rs m99,16330,732 322.7%   
No. of employees `0002.91.0 302.8%   
Total wages/salary Rs m2,758416 662.2%   
Avg. sales/employee Rs Th6,981.75,236.1 133.3%   
Avg. wages/employee Rs Th954.5436.5 218.7%   
Avg. net profit/employee Rs Th771.1995.5 77.5%   
INCOME DATA
Net Sales Rs m20,1704,995 403.8%  
Other income Rs m857194 443.1%   
Total revenues Rs m21,0285,189 405.3%   
Gross profit Rs m4,3101,233 349.7%  
Depreciation Rs m1,239167 740.8%   
Interest Rs m554 9.6%   
Profit before tax Rs m3,9231,205 325.7%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m990-   
Tax Rs m1,794255 703.7%   
Profit after tax Rs m2,228950 234.6%  
Gross profit margin %21.424.7 86.6%  
Effective tax rate %45.721.2 216.1%   
Net profit margin %11.019.0 58.1%  
BALANCE SHEET DATA
Current assets Rs m16,2994,986 326.9%   
Current liabilities Rs m7,5941,042 728.6%   
Net working cap to sales %43.279.0 54.7%  
Current ratio x2.14.8 44.9%  
Inventory Days Days6561 107.0%  
Debtors Days Days2639 65.8%  
Net fixed assets Rs m8,6223,126 275.9%   
Share capital Rs m458127 359.4%   
"Free" reserves Rs m20,7223,717 557.4%   
Net worth Rs m21,1806,236 339.6%   
Long term debt Rs m25432 5.8%   
Total assets Rs m29,1378,079 360.6%  
Interest coverage x755.523.2 3,252.6%   
Debt to equity ratio x00.1 1.7%  
Sales to assets ratio x0.70.6 112.0%   
Return on assets %7.712.4 61.7%  
Return on equity %10.515.2 69.1%  
Return on capital %19.018.9 100.6%  
Exports to sales %0.187.5 0.1%   
Imports to sales %17.512.2 142.9%   
Exports (fob) Rs m124,371 0.3%   
Imports (cif) Rs m3,526611 577.2%   
Fx inflow Rs m524,666 1.1%   
Fx outflow Rs m140942 14.9%   
Net fx Rs m-883,724 -2.4%   
CASH FLOW
From Operations Rs m3,436922 372.7%  
From Investments Rs m-6,991-619 1,128.8%  
From Financial Activity Rs m-619-698 88.6%  
Net Cashflow Rs m-4,174-396 1,054.7%  

Share Holding

Indian Promoters % 0.0 63.4 -  
Foreign collaborators % 63.9 0.0 -  
Indian inst/Mut Fund % 7.5 0.0 -  
FIIs % 4.9 0.0 -  
ADR/GDR % 0.0 0.0 -  
Free float % 23.7 36.5 64.9%  
Shareholders   85,207 37,287 228.5%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare PFIZER With:   ABBOTT INDIA  JUBILANT LIFE SCIENCES  BIOCON LTD  PIRAMAL ENTERPRISES  ALKEM LABORATORIES  

Compare PFIZER With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Global Stock Markets Chart Modest Gains(RoundUp)

Global financial markets ended the holiday shortened week with modest gains. The rally put behind days of decline as concerns regarding swift interest rates hikes were put to ease.

Related Views on News

Suven Lifesciences: Profits Decline due to Higher tax outgo in the quarter (Quarterly Results Update - Detailed)

Sep 22, 2017

Muted growth in CRAMS segment continues to impact topline.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

Biocon: US Pricing Pressure Takes Toll (Quarterly Results Update - Detailed)

Feb 2, 2018

Pricing pressure in the US and costs of the Malaysian facility hit Biocon's profits in the third quarter.

More Views on News

Most Popular

The Foundation for Sensex 100,000 is Laid(The 5 Minute Wrapup)

Feb 17, 2018

Top three reasons for Tanushree's presentation at Equitymaster Conference to be centered around a possible 30% correction.

India's Rs 1,66,276 Crore Problem(Vivek Kaul's Diary)

Feb 15, 2018

That's the loss, the government owned public sector enterprises are expected to make this year.

The Big Gamble(The Honest Truth)

Feb 15, 2018

Once you accept the fact that elections are round the corner and that this budget is geared to reach a 40% target, everything makes sense.

How I Beat the Index by 2x... And Why I Believe This Could Happen Again(Smart Contrarian)

Feb 12, 2018

Will Microcap Millionaires be able to replicate its past performance of beating the index by 2x?

NPAs Set to Rise Further with New RBI Rules(Chart Of The Day)

Feb 15, 2018

The RBI overhauls bad loan framework. Banks may come under additional pressure due to rising NPAs and increased provisioning.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

PFIZER SHARE PRICE


Feb 23, 2018 (Close)

TRACK PFIZER

PFIZER - STRIDES SHASUN LTD COMPARISON

COMPARE PFIZER WITH

MARKET STATS